HIV-2 is similar to HIV-1 in that they are both: Types of human immunodeficiency ... At this point, the efficacy of the CCR5 inhibitor maraviroc is uncertain, while protease inhibitors have variable ...
A phase 2 trial will evaluate leronlimab’s safety and efficacy for the treatment of patients with microsatellite stable ...
The administration of US President Donald Trump has hollowed out one of the federal offices aimed at ending the nation’s HIV epidemic. The move comes as the administration has also cut hundreds of ...
The F8 formulation is 8 times more concentrated than Egrifta and 2 times more concentrated than the current F4 formulation, Egrifta SV.
3don MSN
If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...
Gender-affirming hormone therapy (GAHT) is associated with significantly improved HIV outcomes for transgender, nonbinary, ...
Two Colorado medical researchers trying to stop HIV and AIDS got letters this month saying their federal funding has been ...
A study published in Lancet HIV Thursday showed that patients who received gender-affirming hormones were 37% less likely to ...
Since 1981, HIV has led to the deaths of more than 700,000 people in the US. More than 1.2 million Americans now live with HIV, according to federal statistics. About 13% of people who have HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback